MX2012006293A - Derivados de pirrolidina como antagonista del receptor nk-3. - Google Patents
Derivados de pirrolidina como antagonista del receptor nk-3.Info
- Publication number
- MX2012006293A MX2012006293A MX2012006293A MX2012006293A MX2012006293A MX 2012006293 A MX2012006293 A MX 2012006293A MX 2012006293 A MX2012006293 A MX 2012006293A MX 2012006293 A MX2012006293 A MX 2012006293A MX 2012006293 A MX2012006293 A MX 2012006293A
- Authority
- MX
- Mexico
- Prior art keywords
- lower alkyl
- halogen
- cycloalkyl
- cyano
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09179797 | 2009-12-18 | ||
| PCT/EP2010/069564 WO2011073160A1 (en) | 2009-12-18 | 2010-12-14 | Pyrrolidine derivatives as nk - 3 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012006293A true MX2012006293A (es) | 2012-07-03 |
Family
ID=43480770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012006293A MX2012006293A (es) | 2009-12-18 | 2010-12-14 | Derivados de pirrolidina como antagonista del receptor nk-3. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20110152233A1 (xx) |
| EP (1) | EP2513084B1 (xx) |
| JP (1) | JP5551267B2 (xx) |
| KR (1) | KR101490004B1 (xx) |
| CN (1) | CN102656157B (xx) |
| BR (1) | BR112012014576A2 (xx) |
| CA (1) | CA2781495A1 (xx) |
| ES (1) | ES2546833T3 (xx) |
| HK (1) | HK1169992A1 (xx) |
| MX (1) | MX2012006293A (xx) |
| RU (1) | RU2561271C2 (xx) |
| WO (1) | WO2011073160A1 (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8022099B2 (en) * | 2008-11-03 | 2011-09-20 | Hoffmann-La Roche Inc. | N-benzyl pyrrolidine derivatives |
| US20110144081A1 (en) * | 2009-12-15 | 2011-06-16 | Henner Knust | Pyrrolidine derivatives |
| US8618303B2 (en) * | 2011-01-07 | 2013-12-31 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives |
| BR112013029201B1 (pt) | 2011-05-13 | 2022-08-09 | Array Biopharma Inc | Compostos de pirrolidinil ureia e pirrolidinil tioureia, seu processo de preparação, seu uso e composições farmacêuticas |
| PT2800738T (pt) * | 2012-01-06 | 2020-06-23 | Novartis Ag | Compostos heterocíclicos e métodos para a utilização dos mesmos |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2824828B1 (fr) * | 2001-05-21 | 2005-05-20 | Sanofi Synthelabo | Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant |
| US7514424B2 (en) * | 2002-12-23 | 2009-04-07 | Janssen Pharmaceutica N.V. | Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists |
| US20070060593A1 (en) * | 2003-06-25 | 2007-03-15 | Kerns Jeffrey K | 4-Carboxamido quinoline derivatives for use as nk-2 and nk-3 |
| US7550487B2 (en) * | 2004-03-26 | 2009-06-23 | Hoffmann-La Roche Inc. | Pyrrolidine-3,4-dicarboxamide derivatives |
| AU2008240804B2 (en) | 2007-04-20 | 2013-02-21 | F. Hoffmann-La Roche Ag | Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists |
| WO2009024502A1 (en) * | 2007-08-22 | 2009-02-26 | F. Hoffmann-La Roche Ag | Pyrrolidine aryl-ether as nk3 receptor antagonists |
| US8063075B2 (en) * | 2008-06-10 | 2011-11-22 | Hoffmann-La Roche Inc. | Pyrrolidine ether derivatives as NK3 receptor antagonists |
| MX2010013311A (es) * | 2008-06-16 | 2010-12-21 | Hoffmann La Roche | Derivados de pirrolidina como antagonistas del receptor de nk2. |
| USRE48334E1 (en) * | 2008-09-19 | 2020-12-01 | Takeda Pharmaceutical Company Limited | Nitrogen-containing heterocyclic compound and use of same |
| US8022099B2 (en) * | 2008-11-03 | 2011-09-20 | Hoffmann-La Roche Inc. | N-benzyl pyrrolidine derivatives |
| US20110144081A1 (en) * | 2009-12-15 | 2011-06-16 | Henner Knust | Pyrrolidine derivatives |
| US8618303B2 (en) * | 2011-01-07 | 2013-12-31 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives |
-
2010
- 2010-12-10 US US12/964,769 patent/US20110152233A1/en not_active Abandoned
- 2010-12-14 BR BR112012014576A patent/BR112012014576A2/pt not_active Application Discontinuation
- 2010-12-14 MX MX2012006293A patent/MX2012006293A/es active IP Right Grant
- 2010-12-14 CA CA2781495A patent/CA2781495A1/en not_active Abandoned
- 2010-12-14 JP JP2012543671A patent/JP5551267B2/ja not_active Expired - Fee Related
- 2010-12-14 KR KR1020127018657A patent/KR101490004B1/ko not_active IP Right Cessation
- 2010-12-14 WO PCT/EP2010/069564 patent/WO2011073160A1/en active Application Filing
- 2010-12-14 EP EP10790561.4A patent/EP2513084B1/en not_active Not-in-force
- 2010-12-14 ES ES10790561.4T patent/ES2546833T3/es active Active
- 2010-12-14 CN CN201080057625.1A patent/CN102656157B/zh not_active Expired - Fee Related
- 2010-12-14 RU RU2012129361/04A patent/RU2561271C2/ru not_active IP Right Cessation
-
2012
- 2012-10-30 HK HK12110830.9A patent/HK1169992A1/xx not_active IP Right Cessation
-
2013
- 2013-03-13 US US13/798,583 patent/US9346786B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2546833T3 (es) | 2015-09-29 |
| KR101490004B1 (ko) | 2015-02-04 |
| CA2781495A1 (en) | 2011-06-23 |
| RU2561271C2 (ru) | 2015-08-27 |
| KR20120096086A (ko) | 2012-08-29 |
| EP2513084B1 (en) | 2015-07-22 |
| HK1169992A1 (en) | 2013-02-15 |
| US20130203728A1 (en) | 2013-08-08 |
| BR112012014576A2 (pt) | 2016-03-01 |
| US9346786B2 (en) | 2016-05-24 |
| CN102656157A (zh) | 2012-09-05 |
| US20110152233A1 (en) | 2011-06-23 |
| EP2513084A1 (en) | 2012-10-24 |
| CN102656157B (zh) | 2015-04-29 |
| JP2013514304A (ja) | 2013-04-25 |
| JP5551267B2 (ja) | 2014-07-16 |
| RU2012129361A (ru) | 2014-01-27 |
| WO2011073160A1 (en) | 2011-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015015893A (es) | 2-fenilimidazo[1,2-a]pirimidinas como agentes formadores de imagen. | |
| TN2015000382A1 (en) | Perfluorinated cyclopropyl fused 1,3- oxazin -2- amine compounds as beta- secretase inhibitors and methods of use | |
| EA201390222A1 (ru) | Гетероциклическое соединение и его применение | |
| PH12016501822A1 (en) | Cyclopropaneamine compound | |
| MX366855B (es) | Compuestos perfluorados de 5,6-dihidro-4h-1,3-oxazin-2-amina como inhibidores de beta-secretasa y metodos de uso. | |
| NZ705135A (en) | Heteroaryl compounds and methods of use thereof | |
| EA201391341A1 (ru) | Производные гетероциклических аминов | |
| MX2008012404A (es) | Derivados de amida y su aplicacion para el tratamiento de enfermedades relacionadas con proteina-g. | |
| ATE486058T1 (de) | Prolinamidderivate als nk3-antagonisten | |
| MX2012006293A (es) | Derivados de pirrolidina como antagonista del receptor nk-3. | |
| MX2010001080A (es) | Pirrolidin-aril-eteres como antagonistas de receptor de nk3. | |
| MX2015014353A (es) | Derivados de 2-fenil- o 2-hetaril-imidazol[1,2-a]piridina. | |
| MX2010001774A (es) | Pirrolidin aril-eteres como antagonistas de receptores de nk3. | |
| MX2011008850A (es) | Derivados de piperidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
| MX354815B (es) | Derivados heterociclicos como receptores asociados con las aminas traza (taars). | |
| MX2012001799A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinona 3 (nk3). | |
| MX343077B (es) | Nuevo derivado de octahidrotienoquinolina, composicion farmaceutica que comprende el derivado, y uso de los mismos. | |
| MX340508B (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
| MX2011008178A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
| ATE546455T1 (de) | Spiropiperidinderivate als nk3-antagonisten | |
| MX2011007506A (es) | Derivados de piperidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
| JO2851B1 (en) | 3-benzofuranil-indole-2-one-3-substituted acetamidopiprazine derivatives, preparations thereof and therapeutic use thereof. | |
| ATE549316T1 (de) | Piperidinderivate als nk3-rezeptorantagonisten | |
| MX2009013116A (es) | Derivados de prolinamida-tetrazol como antagonistas del receptor nk3. | |
| MX2009013186A (es) | Derivados de piperazina y [1,4]diazepan como antagonistas de neurocinina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |